Adents Blog FDA delays UPID verification requirement for saleable returns

FDA has just published a new guidance document to clarify requirements for wholesale distributors in the US who must verify the product identifier upon receipt of a returned product before further distribution as per DSCSA requirements. Taking into account concerns expressed by pharma wholesale distributors and other trading partners and stakeholders, US FDA has published a new guidance document, [...]The post FDA delays UPID verification requirement for saleable returns appeared first on Adents English.